Indication
Gynecologic Neoplasms
3 clinical trials
4 products
1 drug
Product
PLX2853Clinical trial
A Multicenter, Open-Label, Parallel, Phase 2a Study of PLX2853 Monotherapy in Advanced Gynecological Malignancies With a Known ARID1A Mutation and Phase 1b/2a Study of PLX2853/Carboplatin Combination Therapy in Platinum-Resistant Epithelial Ovarian CancerStatus: Terminated, Estimated PCD: 2022-04-25
Product
CarboplatinClinical trial
A Pilot Study Investigating the Effect of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers of Mullerian OriginStatus: Completed, Estimated PCD: 2019-01-31
Product
PembrolizumabClinical trial
Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary CancerStatus: Recruiting, Estimated PCD: 2028-12-30
Drug
TiragolumabProduct
Nilotinib